Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell D Hull

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|September 6, 2015
Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet NeedSerge Korjian, Yazan Daaboul, Rim Halaby, et al.
Thrombosis Research|January 29, 2022
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trialArzu Kalayci, C Michael Gibson, Adrian F Hernandez, et al.
Journal of Thrombosis and Thrombolysis|September 15, 2017
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudyGerald Chi, James L Januzzi, Serge Korjian, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX TrialMegan K Yee, C Michael Gibson, Tarek Nafee, et al.
Pharmaceutical Statistics|August 26, 2017
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudyDouglas F Arbetter, Purva Jain, Megan K Yee, et al.
Journal of Thrombosis and Thrombolysis|December 24, 2022
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX TrialGerald Chi, Francesco Violi, Pasquale Pignatelli, et al.
Intensive Care Medicine|February 20, 2019
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudyGerald Chi, C Michael Gibson, Arzu Kalayci, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Machine learning to predict venous thrombosis in acutely ill medical patientsTarek Nafee, C Michael Gibson, Ryan Travis, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk StratificationC Michael Gibson, Alex C Spyropoulos, Alexander T Cohen, et al.
The International Journal of Cardiovascular Imaging|February 25, 2011
Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED IIIH Dirk Sostman, Kathleen A Jablonski, Pamela K Woodard, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Journal of Cardiovascular Pharmacology and Therapeutics|September 6, 2015
Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet NeedSerge Korjian, Yazan Daaboul, Rim Halaby, et al.
Thrombosis Research|January 29, 2022
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trialArzu Kalayci, C Michael Gibson, Adrian F Hernandez, et al.
Journal of Thrombosis and Thrombolysis|September 15, 2017
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudyGerald Chi, James L Januzzi, Serge Korjian, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX TrialMegan K Yee, C Michael Gibson, Tarek Nafee, et al.
Pharmaceutical Statistics|August 26, 2017
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudyDouglas F Arbetter, Purva Jain, Megan K Yee, et al.
Journal of Thrombosis and Thrombolysis|December 24, 2022
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX TrialGerald Chi, Francesco Violi, Pasquale Pignatelli, et al.
Intensive Care Medicine|February 20, 2019
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudyGerald Chi, C Michael Gibson, Arzu Kalayci, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Machine learning to predict venous thrombosis in acutely ill medical patientsTarek Nafee, C Michael Gibson, Ryan Travis, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk StratificationC Michael Gibson, Alex C Spyropoulos, Alexander T Cohen, et al.
The International Journal of Cardiovascular Imaging|February 25, 2011
Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED IIIH Dirk Sostman, Kathleen A Jablonski, Pamela K Woodard, et al.
Pageof 13